Best doctors for prostate cancer care in Kansas City and throughout Kansas

Prostate cancer is the second leading cause of cancer death in U.S. men. In 2023, there were an estimated 2,680 new prostate cancer diagnoses in Kansas and nearly 5,000 in Missouri. The disease often has no symptoms until it has advanced or spread to other areas of the body, at stage III or stage IV. Yet when found early, at stage I or stage II, prostate cancer is one of the most treatable cancers, with a 10-year survival rate of nearly 98%.

At The University of Kansas Cancer Center, the region's only National Cancer Institute-designated comprehensive cancer center, we tailor prostate cancer treatment to the individual as part of our comprehensive approach to care.

Our multidisciplinary team of prostate cancer subspecialists focuses only on prostate cancer. Together, these experts design effective personalized treatment for each patient based on his tumor's genetic and molecular factors, overall lifestyle and other critical influences.

Our precision cancer therapies integrate a patient's tumor molecular data into all treatment decisions. We do not take a one-size-fits-all approach to treatment because not all prostate cancer is the same. Ensuring you receive personalized treatment means better treatment, better outcomes, a better experience and better survivorship.

The first step in caring for you begins the moment you call.

Request an appointment today.

+18889013681

Leading-edge prostate cancer treatment

Whether you want your elevated PSA assessed or need a 2nd opinion on metastatic prostate cancer, our dedicated disease-specific nurse navigators will support you from the moment you call. Once we have a diagnosis of prostate cancer, we use the following to determine your treatment options:

PSA at diagnosis and genomic testing
Cancer grade and details of biopsy samples
Expert pathology review
3T prostate MRI

which allows for faster scans, clearer pictures and more precise diagnosis
for image-guided treatment strategies

Enhanced PSMA PET imaging, using a radioactive imaging agent that binds to prostate cancer cells, to determine cancer spread

Most prostate cancers are slow growing, and even when they appear aggressive there is often time (up to several months in some situations) to gather all of the information needed to make an informed diagnosis.

This can be a complex decision-making process, and we are here for you. Our approach is team based; the goal is to get the right treatment for you and we have a team of urologic oncologists, radiation oncologists and medical oncologists to help.

Treatment options include:

Active surveillance
Focal therapy
Surgery
Radiation therapy
Systemic therapy
Clinical trials

Why choose The University of Kansas Cancer Center?

The University of Kansas Cancer Center is part of a nationwide network of select cancer research centers established by the National Cancer Institute, part of the National Institutes of Health. NCI-designated cancer centers achieve patient outcomes that are 25% better than those of other centers.
Our dedicated team of prostate cancer doctors comprises fellowship-trained urologic surgical oncologists, urologic medical oncologists, urologic radiation oncologists and urologic pathologists. We provide the most advanced medical and surgical care for prostate cancer patients, including screening and prevention, active surveillance and survivorship. As the region’s largest cancer center, we have 14 locations throughout Kansas City.
Ours is the first and only team in the region offering high-intensity focused ultrasound for prostate cancer. HIFU is a type of minimally invasive focal therapy that uses the energy of sound waves to heat and destroy cancer cells in prostate tumors that have not spread. Because of the precision HIFU offers, we can accurately destroy targeted prostate tissue while preserving the rest of the gland and avoid damage to the erectile nerves and urinary sphincter. Clinicians cite up to 90% preservation of potency and similar preservation of continence. In addition, we offer Retzius-sparing radical prostatectomy, a minimally invasive robotic surgery that allows us to remove the prostate in a less invasive way ̶ dramatically reducing recovery time and unwanted side effects. We offer the most advanced treatments in radiation oncology, including brachytherapy, stereotactic body radiation therapy (SBRT) and SpaceOAR™ and opened the region's first Proton Therapy Center in Kansas. We also offer many prostate cancer clinical trials for early-stage (I and II), advanced and metastatic (stage III and IV) prostate cancer, and are at the forefront of clinical studies with immunotherapy and targeted therapy used to treat prostate cancer.
We are 1 of fewer than 60 NCI-designated comprehensive cancer centers nationwide. NCI-designated cancer centers are the backbone of innovative research and patient care across the country. We treat patients from across the U.S. and around the globe at our multiple locations. Since 2012, we have diagnosed and treated patients from all 50 states (plus Puerto Rico and the Virgin Islands) and 26 countries. These individuals report strong patient-satisfaction scores, including urology care at The University of Kansas Cancer Center, which consistently receives one of the highest patient-satisfaction scores at 95% as reported by Press Ganey.